Neulogy Ventures

Neulogy Ventures was established in 2014 as a Luxembourg-based regulated venture capital fund, targeting investment opportunities in early-stage tech companies established or operating in Slovakia. Built by entrepreneurs for entrepreneurs, the fund seeks to nurture the next generation of innovators to transition toward a knowledge economy.

With €70M assets under management, about 30 portfolio companies spread across 10 countries, and a strong track record investing in new technologies addressing climate change and healthcare, Neulogy Ventures is one of the leading deeptech investors in the CEE region. Neulogy Ventures is the first ever Slovakia-based management company to run fully regulated seed and VC funds structured along the highest industry standards. They have a strong commitment to professional, transparent and hands-on approach to working with both our portfolio companies and our investors.

The investment tickets range between €200M and €3M, and they focus on SMEs established or operating in Slovakia. Neulogy Ventures has raised a total of €23M in a single venture fund, Neulogy Slovak Venture Fund SICAR. This fund was announced on Jan 1, 2014 and raised a total of €23M.

Applicants willing to get in touch with Neulogy Ventures can do it by following this link.

Portfolio: Eyerim, Greenway, Gruveo, Minty.